Breaking News
USFDA APPROVES INFLUENZA VACCINE FROM SEQIRUS
INDEGENE AND CONTIPI MEDICAL LTD FORGE PARTNERSHIP
EU AND ITALY NOT EXPORTING ASTRAZENECA VACCINE TO AUSTRALIA
MEDTECS AND ACO INTERNATIONAL TO START JOINT VENTURE
Skip to content
  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
Medgazette 24

Medgazette 24

Healthcare Latest news, Medical Technology Updated News

  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
  • Home
  • Sanofi

Tag: Sanofi

SANOFI TO PRODUCE JOHNSON & JOHNSON’S COVID-19 VACCINE IN FRANCE

March 2, 2021 medgazettePharamaceuticals

HIGHLIGHTS Sanofi is going to produce Johnson & Johnson’s COVID-19 vaccine in France. At its manufacturing plant, Sanofi will fill vials of COVID-19 vaccine. Plan is to produce 12 million doses per month. French drug maker Sanofi is going to…

Purchase Sanofi Stock for the Reason That It is Undervalued

Purchase Sanofi Stock for the Reason That It is Undervalued

January 8, 2020 Shreyas TannaNews, Research

European pharmaceutical and biotech essentials will be solid in 2020, as indicated by a note Monday from European-based investigators at J.P. Morgan. He downsized Galapagos (GLPG), the average size biotech that marked a coordinated effort to manage Gilead (GILD) in…

Innovative Rare Blood Clotting Disorder Prevention Award Sanofi Wins Prestigious Drug Discovery Award[1 ]

Innovative Rare Blood Clotting Disorder Prevention Award Sanofi Wins Prestigious Drug Discovery Award[1 ]

December 30, 2019 Shreyas TannaNews, Pharamaceuticals

Britain, Dec. 17, 2019/PRNewswire/— Sanofi’s Cablivi ® (caplacizumab), the first nanobody therapy for the treatment of Thrombotic Thrombocytopenic Purpura (aTTP), was given the Drug Discovery of the Year 2020 award by the British Pharmacological Society at last night’s annual conference…

The new strategy by Sanofi

The new strategy by Sanofi

December 11, 2019 Shreyas TannaHealthcare, News, Pharamaceuticals

Into the latest news there are ways new strategies which are derived by the sanofi as well as the capital markets today released a commitment tomorrow in regards with the financial committee to provide the new strategic Framework with good…

Sanofi self-confident in appointing MR. Novartis Hudson as their Chief Executive Officer

June 10, 2019 Shreyas TannaNews

Sanofi is ready to delegate Paul Hudson, a top official with Switzerland’s Novartis, to turn into the French drugmaker’s next CEO from Sept. 1, a source acquainted with the choice told Reuters on Thursday. Current Sanofi SA CEO Olivier Brandicourt…

Strategic Partnership Announced Between Novartis, Otsuka and Verily To Revolutionize Clinical Research

May 24, 2019 Shreyas TannaNews

Verily, an Alphabet organization, today declared key collisions with Novartis, Otsuka, Pfizer Inc. and Sanofi to grow carefully creative, understanding focused clinical research programs utilizing Project Baselines proof age stage and instruments. The Baseline Platform is intended to connect more…

Recent News

IBS AND THE ROYAL SOCIETY TO COOPERATE ON COVID-19

March 3, 2021

SANOFI TO PRODUCE JOHNSON & JOHNSON’S COVID-19 VACCINE IN FRANCE

March 2, 2021

HIKMA DONATES OVER 4 MILLION USD IN MEDICINES

March 1, 2021

USFDA APPROVES POTASSIUM CHLORIDE ER CAPSULES FROM GRANULES INDIA

February 26, 2021

ONWARD THERAPEUTICS AND BIOMUNEX PHARMACEUTICALS SIGN NEW AGREEMENT

February 25, 2021

FRANCE BEGINS DISTRIBUTING COVID VACCINE AMID UK VARIANT WARNING

February 24, 2021

UK HEALTHCARE KENTUCKY’S FIRST EXCELLENT SYSTEM FOR HIDDEN SCAR BREAST CANCER SURGERY

February 23, 2021

RAMONA SEQUEIRA MAY SOON BE CHAIRPERSON OF PHRMA BOARD

February 22, 2021

UK GOVERNMENT EXTENDS WOCKHARDT’S CONTRACT CREATING NEW JOBS

February 19, 2021

ARTIOS PHARMA ANNOUNCES FIRST CLINICAL STUDY REGARDING ADVANCED NEXT-GEN DDR

February 18, 2021

Categories

  • Healthcare
    • Healthcare IT
  • Medicine
  • News
  • Pharamaceuticals
  • Research
Medicine
March 16, 2021

USFDA APPROVES INFLUENZA VACCINE FROM SEQIRUS

HIGHLIGHTS USFDA has approved the expanded age indication of cell-based Quadrivalent influenza…

Medicine
March 10, 2021

GERMANY’S MERCK SIGNS AGREEMENT FOR HEAD AND NECK CANCER DRUG

HIGHLIGHTS Merck has signed an agreement with Debiopharm. This is a €…

  • About Us
  • Authors
  • Contact Us
Copyright © All rights reserved.
Powered by WordPress | Magazine Point by Axle Themes